Thursday, February 13, 2014
This week in
Publication and contact
Engineered Fc g-receptor
engagement enhances broadly neutralizing antibodies (bNAbs) against influenza
Mouse studies suggest bNAbs
engineered to activate Fc g-receptors on immune cells could help prevent
influenza infection. bNAbs that bind the invariant stalk region of hemagglutinin
were modified with Fc regions designed to bind a subset of Fc g-receptors
on immune cells that activate an antiviral response. In a mouse model of
lethal influenza infection, the engineered bNAbs increased survival and
decreased viral titers in the lung compared with antibodies containing Fc
regions that engaged inhibitory Fc g-receptors or were
deficient in Fc g-receptor binding. In humanized mice exclusively
expressing human Fc g-receptors, an engineered HA stalk-specific bNAb
increased survival after viral infection compared with an unmodified bNAb.
Next steps could include building Fc portions into therapeutic bNAbs that
enable interactions with activating Fc g-receptors in the
Published online Feb. 13, 2014
Patent and licensing status
DiLillo, D.J. et al.
published online Jan. 12, 2014;
Contact: Jeffrey V. Ravetch,
The Rockefeller University, New York, N.Y.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]